Search

​Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat to healthcare. Beside the carbapenems – a last-line class of antibiotics – CPE are resistant to most other antibiotics, leaving few options for the treatment of infected patients. In an effort to assess the nature and scale of CPE spread in Europe, a group of European experts is implementing the European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE).

​ECDC published the third annual report of the European Surveillance of Antimicrobial Consumption Network (ESAC-Net).

By endorsing the new global action plan endorsed at the World Health Assembly, WHO Member States agreed to mobilise resources to ensure its implementation and committed to have similar plans at national level by 2017.